ID   CIKS_HUMAN              Reviewed;         574 AA.
AC   O43734; B2RAY9; E1P555; Q5R3A3; Q7Z6Q1; Q7Z6Q2; Q7Z6Q3; Q9H5W2; Q9H6Y3;
AC   Q9NS14; Q9UG72;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   07-APR-2021, entry version 183.
DE   RecName: Full=E3 ubiquitin ligase TRAF3IP2 {ECO:0000303|PubMed:19825828};
DE            EC=2.3.2.27 {ECO:0000269|PubMed:19825828};
DE   AltName: Full=Adapter protein CIKS;
DE   AltName: Full=Connection to IKK and SAPK/JNK;
DE   AltName: Full=E3 ubiquitin-protein ligase CIKS;
DE   AltName: Full=Nuclear factor NF-kappa-B activator 1;
DE            Short=ACT1;
DE   AltName: Full=TRAF3-interacting protein 2;
GN   Name=TRAF3IP2; Synonyms=C6orf2, C6orf4, C6orf5, C6orf6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=10903453; DOI=10.1016/s0378-1119(00)00231-6;
RA   Morelli C., Magnanini C., Mungall A.J., Negrini M., Barbanti-Brodano G.;
RT   "Cloning and characterization of two overlapping genes in a subregion at
RT   6q21 involved in replicative senescence and schizophrenia.";
RL   Gene 252:217-225(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLN-332.
RC   TISSUE=Embryonic kidney;
RX   PubMed=10962024; DOI=10.1073/pnas.160265197;
RA   Li X., Commane M., Nie H., Hua X., Chatterjee-Kishore M., Wald D., Haag M.,
RA   Stark G.R.;
RT   "Act1, an NF-kappa B-activating protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:10489-10493(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=10962033; DOI=10.1073/pnas.190245697;
RA   Leonardi A., Chariot A., Claudio E., Cunningham K., Siebenlist U.;
RT   "CIKS, a connection to Ikappa B kinase and stress-activated protein
RT   kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:10494-10499(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 5), AND VARIANT
RP   GLN-332.
RC   TISSUE=Colon, and Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT GLN-332.
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLN-332.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4), AND VARIANT
RP   GLN-332.
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH TRAF6.
RX   PubMed=12459498; DOI=10.1016/s0014-5793(02)03688-8;
RA   Kanamori M., Kai C., Hayashizaki Y., Suzuki H.;
RT   "NF-kappaB activator Act1 associates with IL-1/Toll pathway adapter
RT   molecule TRAF6.";
RL   FEBS Lett. 532:241-246(2002).
RN   [10]
RP   FUNCTION, MUTAGENESIS OF LEU-303; PRO-318; VAL-319 AND LEU-324, INTERACTION
RP   WITH IL17RA AND TRAF6, AND CATALYTIC ACTIVITY.
RX   PubMed=19825828; DOI=10.1126/scisignal.2000382;
RA   Liu C., Qian W., Qian Y., Giltiay N.V., Lu Y., Swaidani S., Misra S.,
RA   Deng L., Chen Z.J., Li X.;
RT   "Act1, a U-box E3 ubiquitin ligase for IL-17 signaling.";
RL   Sci. Signal. 2:ra63-ra63(2009).
RN   [11]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO PSORS13, VARIANT ASN-19, AND
RP   CHARACTERIZATION OF VARIANT ASN-19.
RX   PubMed=20953186; DOI=10.1038/ng.688;
RA   Huffmeier U., Uebe S., Ekici A.B., Bowes J., Giardina E., Korendowych E.,
RA   Juneblad K., Apel M., McManus R., Ho P., Bruce I.N., Ryan A.W., Behrens F.,
RA   Lascorz J., Bohm B., Traupe H., Lohmann J., Gieger C., Wichmann H.E.,
RA   Herold C., Steffens M., Klareskog L., Wienker T.F., Fitzgerald O.,
RA   Alenius G.M., McHugh N.J., Novelli G., Burkhardt H., Barton A., Reis A.;
RT   "Common variants at TRAF3IP2 are associated with susceptibility to
RT   psoriatic arthritis and psoriasis.";
RL   Nat. Genet. 42:996-999(2010).
RN   [12]
RP   VARIANT PSORS13 ASN-19.
RX   PubMed=20953188; DOI=10.1038/ng.689;
RA   Ellinghaus E., Ellinghaus D., Stuart P.E., Nair R.P., Debrus S.,
RA   Raelson J.V., Belouchi M., Fournier H., Reinhard C., Ding J., Li Y.,
RA   Tejasvi T., Gudjonsson J., Stoll S.W., Voorhees J.J., Lambert S.,
RA   Weidinger S., Eberlein B., Kunz M., Rahman P., Gladman D.D., Gieger C.,
RA   Wichmann H.E., Karlsen T.H., Mayr G., Albrecht M., Kabelitz D.,
RA   Mrowietz U., Abecasis G.R., Elder J.T., Schreiber S., Weichenthal M.,
RA   Franke A.;
RT   "Genome-wide association study identifies a psoriasis susceptibility locus
RT   at TRAF3IP2.";
RL   Nat. Genet. 42:991-995(2010).
RN   [13]
RP   VARIANT CANDF8 ILE-536, CHARACTERIZATION OF VARIANT CANDF8 ILE-536,
RP   FUNCTION, AND INTERACTION WITH IL17RA; IL17RB AND IL17RC.
RX   PubMed=24120361; DOI=10.1016/j.immuni.2013.09.002;
RA   Boisson B., Wang C., Pedergnana V., Wu L., Cypowyj S., Rybojad M.,
RA   Belkadi A., Picard C., Abel L., Fieschi C., Puel A., Li X., Casanova J.L.;
RT   "An ACT1 mutation selectively abolishes interleukin-17 responses in humans
RT   with chronic mucocutaneous candidiasis.";
RL   Immunity 39:676-686(2013).
CC   -!- FUNCTION: E3 ubiquitin ligase that catalyzes 'Lys-63'-linked
CC       polyubiquitination of target protein, enhancing protein-protein
CC       interaction and cell signaling (PubMed:19825828). Transfers ubiquitin
CC       from E2 ubiquitin-conjugating enzyme UBE2V1-UBE2N to substrate protein
CC       (PubMed:19825828). Essential adapter molecule in IL17A-mediated
CC       signaling (PubMed:19825828, PubMed:24120361). Upon IL17A stimulation,
CC       interacts with IL17RA and IL17RC receptor chains through SEFIR domains
CC       and catalyzes 'Lys-63'-linked polyubiquitination of TRAF6, leading to
CC       TRAF6-mediated activation of NF-kappa-B and MAPkinase pathways
CC       (PubMed:19825828). {ECO:0000269|PubMed:19825828,
CC       ECO:0000269|PubMed:24120361}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:19825828};
CC   -!- SUBUNIT: Interacts with IKBKG/NF-kappa B essential modulator, with
CC       CHUK/IKK-alpha and with IKBKB/IKK-beta (PubMed:12459498). Interacts
CC       with TRAF6; this interaction is direct (PubMed:12459498,
CC       PubMed:19825828). Interacts with IL17RA and IL17RC (PubMed:19825828,
CC       PubMed:24120361). Interacts with IL17RB (PubMed:24120361).
CC       {ECO:0000269|PubMed:12459498, ECO:0000269|PubMed:19825828,
CC       ECO:0000269|PubMed:24120361}.
CC   -!- INTERACTION:
CC       O43734; Q96C98: FHL3; NbExp=3; IntAct=EBI-744798, EBI-10229248;
CC       O43734; Q13084: MRPL28; NbExp=3; IntAct=EBI-744798, EBI-723426;
CC       O43734; Q9UFD9: RIMBP3; NbExp=3; IntAct=EBI-744798, EBI-10182375;
CC       O43734; O75716: STK16; NbExp=3; IntAct=EBI-744798, EBI-749295;
CC       O43734; Q9Y4K3: TRAF6; NbExp=4; IntAct=EBI-744798, EBI-359276;
CC       O43734; Q15654: TRIP6; NbExp=3; IntAct=EBI-744798, EBI-742327;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=C6ORF4;
CC         IsoId=O43734-1; Sequence=Displayed;
CC       Name=2; Synonyms=C6ORF5, C6ORF6;
CC         IsoId=O43734-2; Sequence=VSP_004163;
CC       Name=3;
CC         IsoId=O43734-3; Sequence=VSP_035733;
CC       Name=4;
CC         IsoId=O43734-4; Sequence=VSP_040374;
CC       Name=5;
CC         IsoId=O43734-5; Sequence=VSP_004163, VSP_047098;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC   -!- DISEASE: Psoriasis 13 (PSORS13) [MIM:614070]: A common, chronic
CC       inflammatory disease of the skin with multifactorial etiology. It is
CC       characterized by red, scaly plaques usually found on the scalp, elbows
CC       and knees. These lesions are caused by abnormal keratinocyte
CC       proliferation and infiltration of inflammatory cells into the dermis
CC       and epidermis. {ECO:0000269|PubMed:20953186,
CC       ECO:0000269|PubMed:20953188}. Note=Disease susceptibility is associated
CC       with variants affecting the gene represented in this entry.
CC   -!- DISEASE: Candidiasis, familial, 8 (CANDF8) [MIM:615527]: A primary
CC       immunodeficiency disorder with altered immune responses and impaired
CC       clearance of fungal infections, selective against Candida. It is
CC       characterized by persistent and/or recurrent infections of the skin,
CC       nails and mucous membranes caused by organisms of the genus Candida,
CC       mainly Candida albicans. {ECO:0000269|PubMed:24120361}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- CAUTION: The presence of U-box domain is not predicted by SMART and
CC       SWISS-MODEL tools. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15507.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF136405; AAF67445.1; -; mRNA.
DR   EMBL; AF136406; AAF67446.1; -; mRNA.
DR   EMBL; AF136407; AAF67447.1; -; mRNA.
DR   EMBL; AF274303; AAG15367.1; -; mRNA.
DR   EMBL; AF272151; AAG15407.1; -; mRNA.
DR   EMBL; AK025351; BAB15117.1; -; mRNA.
DR   EMBL; AK026602; BAB15507.1; ALT_INIT; mRNA.
DR   EMBL; AK314415; BAG37036.1; -; mRNA.
DR   EMBL; AL050289; CAB43390.1; -; mRNA.
DR   EMBL; AL008730; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z97989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW48285.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48287.1; -; Genomic_DNA.
DR   EMBL; BC002823; AAH02823.1; -; mRNA.
DR   EMBL; BI856094; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS5092.1; -. [O43734-1]
DR   CCDS; CCDS5093.1; -. [O43734-2]
DR   CCDS; CCDS55049.1; -. [O43734-4]
DR   CCDS; CCDS55050.1; -. [O43734-5]
DR   PIR; T08794; T08794.
DR   RefSeq; NP_001157753.1; NM_001164281.2. [O43734-5]
DR   RefSeq; NP_001157755.1; NM_001164283.2. [O43734-4]
DR   RefSeq; NP_671733.2; NM_147200.2. [O43734-1]
DR   RefSeq; NP_679211.2; NM_147686.3. [O43734-2]
DR   RefSeq; XP_006715382.1; XM_006715319.3.
DR   RefSeq; XP_011533688.1; XM_011535386.1.
DR   SMR; O43734; -.
DR   BioGRID; 115979; 44.
DR   IntAct; O43734; 18.
DR   MINT; O43734; -.
DR   STRING; 9606.ENSP00000357750; -.
DR   GlyConnect; 2015; 3 N-Linked glycans (1 site).
DR   GlyGen; O43734; 1 site, 3 N-linked glycans (1 site).
DR   iPTMnet; O43734; -.
DR   PhosphoSitePlus; O43734; -.
DR   BioMuta; TRAF3IP2; -.
DR   jPOST; O43734; -.
DR   MassIVE; O43734; -.
DR   MaxQB; O43734; -.
DR   PaxDb; O43734; -.
DR   PeptideAtlas; O43734; -.
DR   PRIDE; O43734; -.
DR   ProteomicsDB; 49136; -. [O43734-1]
DR   ProteomicsDB; 49137; -. [O43734-2]
DR   ProteomicsDB; 49138; -. [O43734-3]
DR   ProteomicsDB; 49139; -. [O43734-4]
DR   ProteomicsDB; 69454; -.
DR   Antibodypedia; 19327; 428 antibodies.
DR   DNASU; 10758; -.
DR   Ensembl; ENST00000340026; ENSP00000345984; ENSG00000056972. [O43734-1]
DR   Ensembl; ENST00000359831; ENSP00000352889; ENSG00000056972. [O43734-5]
DR   Ensembl; ENST00000368730; ENSP00000498323; ENSG00000056972. [O43734-4]
DR   Ensembl; ENST00000368734; ENSP00000498345; ENSG00000056972. [O43734-4]
DR   Ensembl; ENST00000368735; ENSP00000357724; ENSG00000056972. [O43734-4]
DR   Ensembl; ENST00000368761; ENSP00000357750; ENSG00000056972. [O43734-2]
DR   Ensembl; ENST00000392556; ENSP00000376339; ENSG00000056972. [O43734-1]
DR   GeneID; 10758; -.
DR   KEGG; hsa:10758; -.
DR   UCSC; uc003pvf.5; human. [O43734-1]
DR   CTD; 10758; -.
DR   DisGeNET; 10758; -.
DR   GeneCards; TRAF3IP2; -.
DR   HGNC; HGNC:1343; TRAF3IP2.
DR   HPA; ENSG00000056972; Low tissue specificity.
DR   MalaCards; TRAF3IP2; -.
DR   MIM; 607043; gene.
DR   MIM; 614070; phenotype.
DR   MIM; 615527; phenotype.
DR   neXtProt; NX_O43734; -.
DR   OpenTargets; ENSG00000056972; -.
DR   Orphanet; 1334; Chronic mucocutaneous candidiasis.
DR   PharmGKB; PA25938; -.
DR   VEuPathDB; HostDB:ENSG00000056972.18; -.
DR   eggNOG; ENOG502QTXH; Eukaryota.
DR   GeneTree; ENSGT00940000161944; -.
DR   HOGENOM; CLU_036721_1_0_1; -.
DR   InParanoid; O43734; -.
DR   OMA; QNTHIYN; -.
DR   OrthoDB; 1353706at2759; -.
DR   PhylomeDB; O43734; -.
DR   TreeFam; TF329063; -.
DR   PathwayCommons; O43734; -.
DR   SignaLink; O43734; -.
DR   BioGRID-ORCS; 10758; 6 hits in 989 CRISPR screens.
DR   ChiTaRS; TRAF3IP2; human.
DR   GeneWiki; TRAF3IP2; -.
DR   GenomeRNAi; 10758; -.
DR   Pharos; O43734; Tbio.
DR   PRO; PR:O43734; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; O43734; protein.
DR   Bgee; ENSG00000056972; Expressed in left coronary artery and 224 other tissues.
DR   ExpressionAtlas; O43734; baseline and differential.
DR   Genevisible; O43734; HS.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:Ensembl.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:UniProtKB.
DR   GO; GO:0001783; P:B cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0006959; P:humoral immune response; IBA:GO_Central.
DR   GO; GO:0006954; P:inflammatory response; IEA:UniProtKB-KW.
DR   GO; GO:0097400; P:interleukin-17-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; NAS:UniProtKB.
DR   GO; GO:0002230; P:positive regulation of defense response to virus by host; IDA:CACAO.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB.
DR   InterPro; IPR013568; SEFIR_dom.
DR   Pfam; PF08357; SEFIR; 1.
DR   PROSITE; PS51534; SEFIR; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disease variant; Inflammatory response;
KW   Reference proteome; Transferase; Ubl conjugation pathway.
FT   CHAIN           1..574
FT                   /note="E3 ubiquitin ligase TRAF3IP2"
FT                   /id="PRO_0000089751"
FT   DOMAIN          409..550
FT                   /note="SEFIR"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00867"
FT   REGION          1..256
FT                   /note="Mediates interaction with TRAF6"
FT                   /evidence="ECO:0000269|PubMed:12459498"
FT   VAR_SEQ         1..465
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_040374"
FT   VAR_SEQ         1..421
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_035733"
FT   VAR_SEQ         1..9
FT                   /note="Missing (in isoform 2 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:10903453,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_004163"
FT   VAR_SEQ         463
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_047098"
FT   VARIANT         19
FT                   /note="D -> N (in PSORS13; there is a reducing binding of
FT                   this variant to TRAF6; dbSNP:rs33980500)"
FT                   /evidence="ECO:0000269|PubMed:20953186,
FT                   ECO:0000269|PubMed:20953188"
FT                   /id="VAR_047349"
FT   VARIANT         83
FT                   /note="R -> W (in dbSNP:rs13190932)"
FT                   /id="VAR_031227"
FT   VARIANT         332
FT                   /note="H -> Q (in dbSNP:rs1043730)"
FT                   /evidence="ECO:0000269|PubMed:10962024,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:17974005, ECO:0000269|Ref.7"
FT                   /id="VAR_024307"
FT   VARIANT         536
FT                   /note="T -> I (in CANDF8; abolishes homotypic interactions
FT                   with the SEFIR domain of IL17RA, IL17RB and IL17RC; does
FT                   not affect homodimerization; does not affect SEFIR-
FT                   independent interactions with other proteins;
FT                   dbSNP:rs397518485)"
FT                   /evidence="ECO:0000269|PubMed:24120361"
FT                   /id="VAR_070904"
FT   MUTAGEN         303
FT                   /note="L->G: Loss of E3 ubiquitin ligase activity."
FT                   /evidence="ECO:0000269|PubMed:19825828"
FT   MUTAGEN         318
FT                   /note="P->G: Decreases E3 ubiquitin ligase activity."
FT                   /evidence="ECO:0000269|PubMed:19825828"
FT   MUTAGEN         319
FT                   /note="V->R: Loss of E3 ubiquitin ligase activity."
FT                   /evidence="ECO:0000269|PubMed:19825828"
FT   MUTAGEN         324
FT                   /note="L->R: Decreases E3 ubiquitin ligase activity."
FT                   /evidence="ECO:0000269|PubMed:19825828"
FT   CONFLICT        334
FT                   /note="E -> D (in Ref. 3; AAG15407)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        347
FT                   /note="P -> S (in Ref. 1; AAF67447)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   574 AA;  64666 MW;  4985795466D71422 CRC64;
     MPPQLQETRM NRSIPVEVDE SEPYPSQLLK PIPEYSPEEE SEPPAPNIRN MAPNSLSAPT
     MLHNSSGDFS QAHSTLKLAN HQRPVSRQVT CLRTQVLEDS EDSFCRRHPG LGKAFPSGCS
     AVSEPASESV VGALPAEHQF SFMEKRNQWL VSQLSAASPD TGHDSDKSDQ SLPNASADSL
     GGSQEMVQRP QPHRNRAGLD LPTIDTGYDS QPQDVLGIRQ LERPLPLTSV CYPQDLPRPL
     RSREFPQFEP QRYPACAQML PPNLSPHAPW NYHYHCPGSP DHQVPYGHDY PRAAYQQVIQ
     PALPGQPLPG ASVRGLHPVQ KVILNYPSPW DHEERPAQRD CSFPGLPRHQ DQPHHQPPNR
     AGAPGESLEC PAELRPQVPQ PPSPAAVPRP PSNPPARGTL KTSNLPEELR KVFITYSMDT
     AMEVVKFVNF LLVNGFQTAI DIFEDRIRGI DIIKWMERYL RDKTVMIIVA ISPKYKQDVE
     GAESQLDEDE HGLHTKYIHR MMQIEFIKQG SMNFRFIPVL FPNAKKEHVP TWLQNTHVYS
     WPKNKKNILL RLLREEEYVA PPRGPLPTLQ VVPL
//
